CAS 444722-95-6

Benzenesulfonamide, 4-[[6-(cyclohexylmethoxy)-1H-purin-2-yl]amino]-

Description:

Benzenesulfonamide, 4-[[6-(cyclohexylmethoxy)-1H-purin-2-yl]amino]- is a chemical compound characterized by its complex structure, which includes a benzenesulfonamide moiety and a purine derivative. This compound features a cyclohexylmethoxy group attached to the purine, contributing to its unique properties. It is typically a white to off-white solid and is soluble in organic solvents, with limited solubility in water. The presence of the sulfonamide group suggests potential applications in medicinal chemistry, particularly as a pharmacological agent, due to its ability to interact with biological targets. The purine structure may also indicate potential roles in nucleic acid metabolism or as an enzyme inhibitor. As with many sulfonamides, it may exhibit antibacterial or antiviral properties, although specific biological activities would depend on further empirical studies. Safety and handling precautions should be observed, as with all chemical substances, to mitigate any potential hazards associated with its use.

Formula: C₁₈H₂₂N₆O₃S

NU6102

CAS: 444722-95-6

NU6102

Purity: ≥98%

Molecular weight: 402.47g/mol

Ref: 54-BUP13386

NU6102

CAS: 444722-95-6

NU6102 is a CDK2 inhibitor with antitumor activity against CDK1/cyclinB, CDK1/CDK2, CDK4, DYRK1A , PDK1, and ROCKII, and it can be used to study rectal cancer.

Formula: C₁₈H₂₂N₆O₃S

Purity: 99.76%

Color and Shape: Solid

Molecular weight: 402.47

Ref: TM-T28218

NU6102

CAS: 444722-95-6

Formula: C₁₈H₂₂N₆O₃S

Molecular weight: 402.5

Ref: 7W-GL7670

NU6102

Controlled Product

CAS: 444722-95-6

Formula: C₁₈H₂₂N₆O₃S

Color and Shape: Neat

Molecular weight: 402.471

Ref: TR-N925290

Cdk1/2 Inhibitor II, NU6102

CAS: 444722-95-6

Cdk1/2 Inhibitor II, NU6102 is a potent inhibitor of CDK1 and CDK2 that blocks the activity of these enzymes by binding to them in the ATP-binding site. It has been shown to inhibit transcriptional regulation and cell cycle progression in the G1 phase. This drug also inhibits receptor activity, which may be due to its ability to inhibit intracellular signaling pathways that regulate cell proliferation.

Formula: C₁₈H₂₂N₆O₃S

Purity: Min. 95%

Molecular weight: 402.47 g/mol

Ref: 3D-USA72295